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A 17/3-carboxyl or 178-methoxycarbonyl side chain was not reduced, probably for electronic reasons. In this respect, the reducing power of cortisone reductase resembled that of NaBH4 or lithium tri-t-butoxyaluminium hydride, and was less than that of LiAIH4.
Estimates of the binding of various compounds were obtained from inhibition studies. From these it appeared likely that interactions between the enzyme-NADH complex and the 20-0x0 group contribute little to the stability of the ternary enzyme-NADH-20-0x0 steroid complex. On the other hand, the 20a-hydroxy configuration (instead of the 20jLhydroxy configuration) evidently generates repulsive forces sufficient to offset the forces that normally bind the rest of the steroid molecule to the enzyme-NAD+ complex.
The presence of a hydroxyl group on either of the carbon atoms (C-17 and C-21) adjacent to the reaction site (C-20) did not prevent the enzyme and NAD+ from abstracting the 20a-hydrogen, but in the presence of a hydroxyl group on both of these atoms, this reaction was undetectable. The joint presence of these neighbouring hydroxyl groups would be expected on electronic grounds to make hydride abstraction more difficult, but other enzymes (EC 1.1.1.6 and 1.1.1.94) catalyse the analogous oxidation of the 2-hydroxyl group of glycerol or glycerol phosphate. (Fukuda et al., 1973) and has been obtained in a crystalline form from the culture fluid of Brevibacterium sterolicum (Uwajima et af., 1973 (Uwajima et af., , 1974 . The purification of cholesterol oxidase from Nocardia species has been reported (Flegg, 1973; Richmond, 1973) , and this enzyme is now commercially available for the clinical estimation of cholesterol. The enzyme effects the oxidation of cholesterol to 4-cholesten-3-one in the presence of oxygen (with the concomitant formation of H202), but it is not specific for cholesterol (Flegg, 1973 ; Richmond, 1973; Allain et al., 1974; Uwajima et al., 1974) . We have used the enzyme in the characterization of 26-hydroxycholestero1 and in the analysis of 38-hydroxy steroids by g.1.c. . A more detailed investigation of the substrate specificity of cholesterol oxidase from Nocardia erythropolis is now reported. The enzyme comprises a 38-hydroxy steroid oxidase and a A5-steroid isomerase component. To determine the rate of steroid oxidation alone, the H202 generated was measured by the oxidative coupling of an excess of horseradish peroxidase (HzOz oxidoreductase, EC 1.1.11.7) to give a quinone-imine dye (Trinder, 1969; Allain et al., 1974) .
Steroids in propan-2-01 (50~1) were mixed with 2.75m1 of 50 ~M -N~H , P O~-N~~H P O~ buffer (pH7.0) containing 1 mg of Triton X-IOO/ml, 0.1 ml of 4:aminoantipyrine ( 2 . 4 m~) and 0.1 mI of phenol ( 0 . 4~) in a cuvette of 1 cm light-pathmaintained at 30°C. Incubations were initiated by the addition of peroxidase [0.18 unit (,umol/min)] and cholesterol oxidase (usually 0.02 unit) in buffer (10~1). The rate of production of H2O2 was indicated by the increase in extinction at 500nm. The initial rates determined for seven
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BIOCHEMICAL SOCIETY TRANSACTIONS substrate concentrations in duplicate, or five in triplicate, were used to determine kinetic constants. Provisional values of K,,, @M) and V (pmol-min-' .mg-' of enzyme) were obtained by the graphical method of Eisenthal & Cornish-Bowden (1974) . These were then estimated more precisely by using a computer program for a least-squares adjustment of the Michaelis-Menten curve (Wentworth, 1965 ) on a Digico Micro 16P computer. The products of enzymic oxidations were identified by g.1.c.-mass spectrometry.
A series of A5-38-hydroxy steroids with hydroxylated side chains was used to explore the requirements of cholesterol for side chain length (Table 1) . 17~-(Hydroxymethyl)-5-androsten-38-01, with a C1 side chain, and S-androstene-3/?,17jl-diol with no side chain, were only slowly oxidized by the enzyme, and the K,,,/V values (which may be broadly regarded as an inverse measure of enzyme efficiency) were approx. 60 times as high as for cholesterol. With S-pregnene-38,208-diol and 23,24-dinor-5-cholene-38,22-diol (C, and C3 side chains respectively) oxidation proceeded at a relatively high rate. Though 25-hydroxy-27-norcholesterol and 26-hydroxycholestero1, with C, and C8 side chains respectively, were oxidized more slowly than cholesterol, the three Km/ V values were comparable. The changes in K,,, values in this series were only eightfold, as compared with a 58-fold change in V, suggesting that the G17 side chain does not greatly affect the degree of binding but that it may serve to orientate the steroid correctly relative to the active site concerned with oxidation.
The very poor binding of 20,25-diazacholesterol to the enzyme is attributed to an adverse effect of the two basic centres: we have also noticed that the alkaloid solasodine is virtually unattacked by the enzyme, whereas its oxygen analogue, diosgenin, is a moderately good substrate. 5a-Cholestan-38-01 and 4-cholesten-3~-ol were comparable with cholesterol in their susceptibility to oxidation, but 5a-cholest-7-en-3/3-ol, 5a-cholest-8( 14)-en-38-01 and 5,7-cholestadien-3~-01 were poorer substrates. 4,CDimethyl groups greatly decreased the rate of oxidation, and 4a-methylcholesterol was oxidized only oneeighth as fast as the 48 isomer, suggesting steric interference, particularly by the 4a-methyl group, in the removal of the 3a-hydrogen. (Relative-rate studies also showed that 48-hydroxycholestero1 was oxidized five times faster than the 4a-isomer.) Little or no oxidation was observed with 5~-cholestan-3~-ol or with 3a-hydroxy steroids. Sa-Cholestan-2&01 was not a substrate. Cholecalciferol has been reported to be a substrate for certain enzymes acting on cholesterol (Fraser & Kodicek, 1968 ), but was not oxidized by cholesterol oxidase.
